The company Neuralink, owned by Elon Musk, has implanted a chip in the brain of a third patient. To clarify, this patient is a human being. This is just the beginning of this year's plans. The American neurotechnology company from San Francisco plans to conduct dozens of such operations by the end of 2025.

Neuralink’s three implants are part of its ongoing Prime study, which is evaluating the safety of Neuralink’s brain device in individuals with quadriplegia. In September 2024, the company announced the approval of a second study known as Convoy, which will explore extending its brain device capabilities to control an assistive robotic arm.

Elon Musk 's neurotechnology company Neuralink has successfully implanted its brain-computer interface (BCI) device in a third human patient. Musk announced the milestone during an event in Las Vegas. "We've got now three humans with Neuralinks implanted and they're all working well," he said.

Elon Musk revealed that Neuralink's brain-computer device has been successfully implanted in a third patient, with plans for 20 to 30 more implants this year. He confirmed that all three implants are working well, sharing the update during a Las Vegas event streamed on his X platform, formerly known as Twitter.

Elon Musk's Neuralink brain implant has been approved by Health Canada for clinical trials in Canada. Dr. Andres Lozano, a neurosurgeon at Toronto Western Hospital, discusses the upcoming clinical trials and how the technology could help people with disabilities due to spinal cord injuries or ALS.

Elon Musk announced that Neuralink has implanted its third patient, marking a milestone. The company is upgrading its brain-computer interface and plans to expand trials with 20-30 more implants this year,